Addressing Heart & Lifestyle Diseases with Nutraceuticals
India, Feb. 8 -- In India, the treatment of Cardiovascular Diseases (CVD) market is estimated to achieve a revenue of $10.52 billion by 2024. Looking ahead, the market is projected to experience a compound annual growth rate (CAGR 2024-2028) of 6.59 per cent. This growth will lead to a market volume of $13.58 billion by 2028.
In terms of global comparison, the United States is anticipated to generate the highest revenue in the CVDs market, reaching a staggering $134.10 billion in 2024. India's growing middle class and increasing access to healthcare drive demand for innovative treatments for CVDs, according to a report by Statista. Over the past few decades, health and fitness have become a priority for people. Hence, there is a special ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.